How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Roche Molecular Systems Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
52 clearance records and 66 recall records in the covered releases, across 1 source company names and 37 product codes. Dated history runs from Jun 15, 1993 to Aug 28, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 3 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 2 | 0 |
| August 2026 | 2 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative Control Kit for use on the co…K260045 · OZN | Roche Molecular Systems, Inc. | 510(k) | Aug 28, 2026FDA decision date |
| cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas Strep A Quality Control Kit (07402678190)K260047 · PGX | Roche Molecular Systems, Inc. | 510(k) | Aug 28, 2026FDA decision date |
| cobas® BV/CVK260021 · PQA | Roche Molecular Systems, Inc. | 510(k) | Jul 16, 2026FDA decision date |
| cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systemsK260917 · QEP | Roche Molecular Systems, Inc. | 510(k) | Jul 8, 2026FDA decision date |
| cobas liat CT/NG nucleic acid testK253756 · QEP | Roche Molecular Systems, Inc. | 510(k) | May 15, 2026FDA decision date |
| cobas liat CT/NG/MG nucleic acid testK253759 · QEP | Roche Molecular Systems, Inc. | 510(k) | May 15, 2026FDA decision date |
| cobas liat Bordetella panel nucleic acid testK243753 · OZZ | Roche Molecular Systems, Inc. | 510(k) | Nov 20, 2025FDA decision date |
| cobas CMVK252481 · PAB | Roche Molecular Systems, Inc. | 510(k) | Nov 3, 2025FDA decision date |
| cobas HCVK252484 · MZP | Roche Molecular Systems, Inc. | 510(k) | Nov 3, 2025FDA decision date |
| cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 SystemsK243455 · QOF | Roche Molecular Systems, Inc. | 510(k) | Jul 31, 2025FDA decision date |
| Opulus Lymphoma PrecisionK243863 · QIH | Roche Molecular Systems, Inc. | 510(k) | May 30, 2025FDA decision date |
| cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid testK243400 · QOF | Roche Molecular Systems, Inc. | 510(k) | Apr 25, 2025FDA decision date |
| cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid testK243406 · QOF | Roche Molecular Systems, Inc. | 510(k) | Apr 25, 2025FDA decision date |
| cobas liat SARS-CoV-2 v2 nucleic acid testK243346 · QWR | Roche Molecular Systems, Inc. | 510(k) | Apr 11, 2025FDA decision date |
| cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 SystemsK240867 · QQX | Roche Molecular Systems, Inc. | 510(k) | Feb 11, 2025FDA decision date |
| cobas® liat CT/NG nucleic acid testK240217 · QEP | Roche Molecular Systems, Inc. | 510(k) | Jan 17, 2025FDA decision date |
| cobas® liat CT/NG/MG nucleic acid testK240197 · QEP | Roche Molecular Systems, Inc. | 510(k) | Jan 16, 2025FDA decision date |
| cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat SystemK223783 · QWR | Roche Molecular Systems, Inc. | 510(k) | Dec 4, 2023FDA decision date |
| cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® SystemK223591 · QOF | Roche Molecular Systems, Inc. | 510(k) | Jul 27, 2023FDA decision date |
| cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 SystemsK231306 · QQX | Roche Molecular Systems, Inc. | 510(k) | Jun 1, 2023FDA decision date |
| cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Material number 09233474190Z-1104-2023 · QLT | Roche Molecular Systems, Inc. | Recall | Feb 7, 2023FDA classification date |
| cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190Z-1105-2023 · QLT | Roche Molecular Systems, Inc. | Recall | Feb 7, 2023FDA classification date |
| cobas Influenza A/B & RSV UC (Utility Channel) Qualitative nucleic acid test for use on the cobas 6800/8800 Systems; Material number 09233962190Z-1106-2023 · QLT | Roche Molecular Systems, Inc. | Recall | Feb 7, 2023FDA classification date |
| cobas HCVK221007 · MZP | Roche Molecular Systems, Inc. | 510(k) | Nov 4, 2022FDA decision date |
| cobas SARS-CoV-2 Qualitative for use on the cobas 6800/8800 SystemsK213804 · QQX | Roche Molecular Systems, Inc. | 510(k) | Oct 22, 2022FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.